Clinically, patients with large granular lymphocyte leukemias tended to have significantly smaller cells if their cells demonstrated STAT3 mutations in the SH2 domain compared to patients whose cells did not have STAT3 mutations [27]. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.